Concepedia

Publication | Closed Access

Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1: Predictors of Poor Response to Tamoxifen Therapy in Recurrent Breast Cancer

DOI

157

Citations

0

References

1995

Year

John A. Foekens, Maxime P. Look, Harry A. Peters, Wim L.J. van Putten, Henk Portengen, J.G.M. Klijn
JNCI Journal of the National Cancer Institute

Abstract

Measurement of primary breast tumor uPA levels may be useful in predicting the overall response of metastatic disease to tamoxifen therapy.